Naxicap Partners has acquired Groupe Moria
Naxicap Partners has acquired Groupe Moria from Bridgepoint Development Capital.
Naxicap Partners is a French private equity firm operating in all sectors and focusing on leverage buy-outs and growth capital. For more than 30 years, the firm has invested in ambitious companies in France, Benelux and Spain through controlling majority stakes. As of 31/12/2017, Naxicap Partners manages US$3.5 billion for BPCE Group (33%) and for global institutional investors (67%).
Groupe Moria manufactures and distributes ophthalmic surgery consumables, single use and reusable instruments addressing refractive, corneal, cataract and retinal procedures. The company benefits from strong know-how, combining handcraft capabilities and state-of-the-art technology located in two industrial facilities in France. Present in nearly 80 countries, the group reaches its end customers worldwide through to a tier-2 distribution model (direct sales to surgeons and healthcare facilities and indirect sales via distributors and wholesalers).
Bridgepoint Development Capital is a major international private equity group focused on buy-outs and growth capital investments, typically in businesses with an enterprise value of between US$22–267 million. The firm currently operates in the UK, France and the Nordic region.
Oaklins' team in France advised the buyer in this transaction.
Talk to the deal team
GeneTech Inc. has been acquired by Eurofins
Noritsu Koki Ltd. has sold GeneTech Inc. to Eurofins Clinical Testing Holding Lux S.à r.l.Learn more
MediCa group has been acquired by Repharm
CGP Management has sold MediCa group, the largest private provider of healthcare services in Lithuania, to Repharm.Learn more
The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)
The shareholders of The MOLE Clinic Limited have sold the company to Sk:n.Learn more